Naotomo Kambe Selected Research

Immunoglobulins (Immunoglobulin)

12/2023	Neutrophilic epitheliotropism, proposed as an auto-inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases.
11/2021	Refractory serum immunoglobulin M elevation during anti-interleukin (IL)-1- or IL-6-targeted treatment in four patients with Schnitzler syndrome.
7/2002	Late-phase urticaria Update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naotomo Kambe Research Topics

Disease

8	Blau syndrome 01/2023 - 02/2005
8	Cryopyrin-Associated Periodic Syndromes 11/2021 - 11/2005
6	Urticaria (Hives) 12/2023 - 05/2009
6	Exanthema (Rash) 12/2023 - 05/2009
5	Inflammation (Inflammations) 01/2021 - 03/2008
4	Sarcoidosis (Schaumann Disease) 12/2023 - 07/2017
4	Atopic Dermatitis (Atopic Eczema) 01/2023 - 01/2008
4	Pruritus (Itching) 01/2022 - 01/2008
4	Contact Dermatitis (Eczema, Contact) 01/2022 - 06/2010
3	Pain (Aches) 12/2023 - 03/2008
3	Fever (Fevers) 12/2023 - 03/2008
3	Granuloma 12/2023 - 08/2005
3	Hypersensitivity (Allergy) 01/2022 - 12/2006
2	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 04/2024 - 01/2019
2	Leukocytosis (Pleocytosis) 12/2023 - 11/2021
2	Schnitzler Syndrome 12/2023 - 11/2021
2	Dermatitis 10/2023 - 06/2010
2	Skin Manifestations 01/2022 - 06/2010
2	Hyperplasia 01/2021 - 10/2015
2	Hereditary leiomyomatosis and renal cell cancer 12/2020 - 01/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2019 - 05/2018
2	Necrosis 02/2008 - 04/2007
1	Multiple Myeloma 04/2024
1	Bullous Pemphigoid (Pemphigoid) 04/2024
1	Herpes Zoster 10/2023
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 07/2023
1	Lymphoma (Lymphomas) 04/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2023
1	Kimura Disease 01/2023
1	Neoplasms (Cancer) 02/2021
1	Disease Progression 07/2019
1	Chronic Urticaria 07/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Pityriasis Rubra Pilaris 01/2019
1	Exfoliative Dermatitis (Erythroderma) 01/2019
1	Lung Diseases (Lung Disease) 07/2017

Drug/Important Bio-Agent (IBA)

7	NucleotidesIBA 01/2022 - 05/2009
5	CytokinesIBA 01/2023 - 06/2010
5	NF-kappa B (NF-kB)IBA 04/2013 - 02/2005
4	InflammasomesIBA 01/2019 - 05/2009
3	Immunoglobulin E (IgE)IBA 04/2024 - 12/2006
3	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 07/2002
3	Muramidase (Lysozyme)IBA 12/2023 - 07/2017
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2023 - 07/2017
3	Immunoglobulin M (IgM)IBA 07/2023 - 11/2021
3	Omalizumab (Xolair)FDA Link 01/2022 - 07/2019
3	Histamine Antagonists (Antihistamines)IBA 01/2022 - 01/2008
3	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 01/2008
3	InterleukinsIBA 11/2021 - 05/2009
3	LigandsIBA 01/2021 - 01/2009
2	Immunoglobulin G (IgG)IBA 04/2024 - 12/2023
2	C-Reactive ProteinIBA 12/2023 - 11/2021
2	EnzymesIBA 12/2023 - 11/2005
2	GlucocorticoidsIBA 12/2023 - 07/2002
2	SteroidsIBA 12/2023 - 01/2022
2	canakinumab FDA Link 04/2023 - 11/2021
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2023 - 11/2021
2	Interleukin-1 (Interleukin 1)IBA 04/2023 - 09/2010
2	Janus Kinase InhibitorsIBA 01/2023 - 01/2022
2	Interleukin-13IBA 01/2023 - 01/2021
2	Fumarate Hydratase (Fumarase)IBA 12/2020 - 01/2013
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2018 - 07/2017
2	Proteins (Proteins, Gene)FDA Link 10/2017 - 07/2002
2	Leucine (L-Leucine)FDA Link 06/2010 - 05/2009
1	Proteasome InhibitorsIBA 04/2024
1	ixazomibIBA 04/2024
1	RNA (Ribonucleic Acid)IBA 12/2023
1	Fructose-BisphosphataseIBA 12/2023
1	Rituximab (Mabthera)FDA Link 04/2023
1	tofacitinibIBA 01/2023
1	baricitinibIBA 01/2023
1	tralokinumabIBA 01/2023
1	Janus KinasesIBA 01/2023
1	OxazoloneIBA 01/2022
1	Surface-Active Agents (Surfactants)IBA 01/2022
1	IgE Receptors (Fc epsilon RI)IBA 01/2022
1	Irritants (Vesicants)IBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 11/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021
1	crisaboroleIBA 01/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	delgocitinibIBA 01/2021
1	dupilumabIBA 01/2021
1	Tetradecanoylphorbol AcetateIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020
1	AntigensIBA 03/2020
1	AntibodiesIBA 03/2020
1	Peptides (Polypeptides)IBA 06/2019
1	Nerve Growth Factor (NGF)IBA 06/2019
1	Imiquimod (Aldara)FDA LinkGeneric 06/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	Dasatinib (BMS 354825)FDA Link 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2018
1	Tuberculin (PPD)IBA 07/2017
1	Secretory Phospholipases A2IBA 10/2015

Therapy/Procedure

11	Therapeutics 12/2023 - 03/2008
1	Phototherapy (Light Therapy) 10/2023